Insurance stocks are topping the IBD 50 as investors turn to more defensive names as former leading growth stocks continue to ...

Compounding pharmacy and IBD 50 newcomer Hims & Hers Health reported bullish earnings and sales growth late Monday. But Hims stock tanked. Please watch the video at Investors.com - The Weight-Loss ...

I believe there is a good chance they will recover when management states that fundamentals are unchanged and they are progressing well.

37,249 people played the daily Crossword recently. Can you solve it faster than others?37,249 people played the daily Crossword recently. Can you solve it faster than others?

35,009 people played the daily Crossword recently. Can you solve it faster than others?35,009 people played the daily Crossword recently. Can you solve it faster than others? Elon Musk Clashes ...

Doctors may use blood, stool, and imaging tests to help diagnose IBD. However, endoscopy with biopsy is often essential to confirming a diagnosis and distinguishing between the two types.

Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.

Chan and colleagues used deidentified electronic health record data from TriNetX to compare the risk for major adverse cardiovascular events among patients with IBD aged 50 years and older treated ...

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3% and the actively trad NVIDIA reports blockbuster fourth-quarter fiscal 2025 results powered by new AI Blackwell chips ...

Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education ...